Study of two drugs for spontaneous brain bleed recovery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have a spontaneous brain bleed (not from injury or an aneurysm) seen on a scan
- You arrived at the hospital within 24 hours of your first symptom
- You have moderate to severe stroke symptoms (NIHSS score higher than 8) and a Glasgow Coma Scale score of 8 or more
- You do not have chronic kidney disease or other serious illnesses that could interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of a minimally invasive surgery to remove the brain bleed and a medication called deferoxamine (which may help reduce damage from the bleed). The goal is to see if this combination helps improve recovery after a brain hemorrhage.
This trial tests whether an antibiotic called minocycline can help people who have had a bleeding stroke (intracerebral hemorrhage). The drug may reduce brain swelling and improve recovery. You must start treatment within 24 hours of the bleeding.
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
This study looks at how inflammation and the brain's protective barrier are affected after a hemorrhagic stroke. It uses special brain scans to see these changes, which might help guide future care.
This study tests whether a medicine called levetiracetam can help people recover better after a brain bleed. Half of the participants will receive the medicine, and half will receive a placebo. The goal is to see if this medicine can help improve recovery.
This study looks at people who have had a brain bleed (intracerebral hemorrhage) to learn more about their recovery over time. It does not involve a new treatment but rather follows participants to understand the condition better.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.